{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T17:08:14Z","timestamp":1781975294795,"version":"3.54.5"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["NN402243635"],"award-info":[{"award-number":["NN402243635"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","award":["502-01-0221964403168"],"award-info":[{"award-number":["502-01-0221964403168"]}],"id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.psychres.2018.11.041","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T12:22:18Z","timestamp":1542630138000},"page":"89-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters."],"prefix":"10.1016","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5634-1061","authenticated-orcid":false,"given":"Maria","family":"Skibinska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Kapelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Rajewska-Rager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-9106","authenticated-orcid":false,"given":"Aleksandra","family":"Szczepankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Narozna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Duda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Budzinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Twarowska-Hauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Dmitrzak-Weglarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Pawlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0001","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.21139","article-title":"Mouse and rat BDNF gene structure and expression revisited","volume":"85","author":"Aid","year":"2007","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0002","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/sji.12158","article-title":"Changes in serum levels of brain derived neurotrophic factor and nerve growth factor-beta in schizophrenic patients before and after treatment","volume":"80","author":"Ajami","year":"2014","journal-title":"Scand. J. Immunol."},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.mp.4001637","article-title":"BDNF in schizophrenia, depression and corresponding animal models","volume":"10","author":"Angelucci","year":"2005","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2018.11.041_bib0004","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jpsychires.2013.05.032","article-title":"Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia","volume":"47","author":"Asevedo","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.psychres.2018.11.041_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189373","article-title":"Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia","volume":"12","author":"Bakirhan","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1099800417735634","article-title":"Serum BDNF is positively associated with negative symptoms in older adults with schizophrenia","volume":"20","author":"Binford","year":"2018","journal-title":"Biol. Res. Nurs."},{"issue":"5","key":"10.1016\/j.psychres.2018.11.041_bib0007","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bdi.12294","article-title":"The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia","volume":"17","author":"Bonaccorso","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.psychres.2018.11.041_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/978143","article-title":"Relationship between levels of brain-derived neurotrophic factor and metabolic parameters in patients with type 2 diabetes mellitus","author":"Boyuk","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.psychres.2018.11.041_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.metabol.2017.11.019","article-title":"Developmental origins of adult health and disease: the metabolic role of BDNF from early life to adulthood","volume":"81","author":"Briana","year":"2018","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0010","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-009-1665-6","article-title":"Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes","volume":"207","author":"Chen","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psychres.2018.11.041_bib0011","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/9780470751251.ch14","article-title":"Impact of genetic variant BDNF (Val66Met) on brain structure and function","volume":"289","author":"Chen","year":"2008","journal-title":"Novartis Found Symp."},{"issue":"5","key":"10.1016\/j.psychres.2018.11.041_bib0012","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15622975.2016.1224925","article-title":"Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naive first-episode schizophrenia: Effects of antipsychotics","volume":"18","author":"Chiou","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.11.041_bib0013","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.schres.2016.09.012","article-title":"Prevalence of metabolic syndrome in female and male patients at risk of psychosis","volume":"181","author":"Cordes","year":"2016","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.psychres.2018.11.041_bib0014","first-page":"250","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia: a systematic review","volume":"24","author":"Cui","year":"2012","journal-title":"Shanghai Arch. Psychiatry"},{"key":"10.1016\/j.psychres.2018.11.041_bib0015","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fnbeh.2017.00240","article-title":"Immediate-early genes modulation by antipsychotics: translational implications for a putative gateway to drug-induced long-term brain changes","volume":"11","author":"de Bartolomeis","year":"2017","journal-title":"Front Behav. Neurosci."},{"issue":"12","key":"10.1016\/j.psychres.2018.11.041_bib0016","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2018.11.041_bib0017","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/mp.2014.117","article-title":"Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications","volume":"20","author":"Fernandes","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.11.041_bib0018","series-title":"Structured clinical interview for DSM-IV Axis I disorders, clinician version (SCID-CV)","author":"First","year":"1996"},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0019","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2007.04.001","article-title":"Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder","volume":"420","author":"Gama","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0020","doi-asserted-by":"crossref","first-page":"e10099","DOI":"10.1371\/journal.pone.0010099","article-title":"Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging","volume":"5","author":"Golden","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.psychres.2018.11.041_bib0021","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2010.88","article-title":"Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis","volume":"16","author":"Green","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0022","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2005.05.001","article-title":"Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan","volume":"80","author":"Huang","year":"2005","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0023","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.psychres.2018.11.041_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.psychres.2018.11.041_bib0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/08039488.2017.1340518","article-title":"Brain-derived neurotrophic factor serum and plasma levels in the treatment of acute schizophrenia with olanzapine or risperidone: 6-week prospective study","volume":"71","author":"Kudlek Mikulic","year":"2017","journal-title":"Nord. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0026","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.npp.1300382","article-title":"BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits","volume":"29","author":"Lang","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0027","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0b013e31821895c1","article-title":"Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment","volume":"31","author":"Lee","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.psychres.2018.11.041_bib0028","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/NMD.0000000000000463","article-title":"Levels of serum brain-derived neurotrophic factor in schizophrenia","volume":"204","author":"Lee","year":"2016","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2018.11.041_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eurpsy.2016.03.005","article-title":"Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia","volume":"36","author":"Li","year":"2016","journal-title":"Eur. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2018.11.041_bib0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.12740\/PP\/37705","article-title":"BDNF as a biomarker in the course and treatment of schizophrenia","volume":"49","author":"Libman-Sokolowska","year":"2015","journal-title":"Psychiatr. Pol."},{"issue":"22","key":"10.1016\/j.psychres.2018.11.041_bib0031","doi-asserted-by":"crossref","first-page":"e7089","DOI":"10.1097\/MD.0000000000007089","article-title":"Increased serum brain-derived neurotrophic factor in male schizophrenic patients with metabolic syndrome","volume":"96","author":"Lin","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0032","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0888-7543(91)90436-I","article-title":"Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations","volume":"10","author":"Maisonpierre","year":"1991","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0033","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/0253-7176.119471","article-title":"Metabolic syndrome in schizophrenia","volume":"35","author":"Malhotra","year":"2013","journal-title":"Indian J. Psychol. Med."},{"issue":"8","key":"10.1016\/j.psychres.2018.11.041_bib0034","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/archpsyc.1991.01810320088015","article-title":"A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system","volume":"48","author":"McGuffin","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neulet.2011.10.042","article-title":"Association of biomarkers and depressive symptoms in schizophrenia","volume":"505","author":"Noto","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.psychres.2018.11.041_bib0036","first-page":"237","article-title":"BDNF function and intracellular signaling in neurons","volume":"25","author":"Numakawa","year":"2010","journal-title":"Histol. Histopathol."},{"issue":"1-3","key":"10.1016\/j.psychres.2018.11.041_bib0037","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.schres.2014.05.024","article-title":"The relationship between serum brain-derived neurotrophic factor (BDNF) and cardiometabolic indices in schizophrenia","volume":"157","author":"Nurjono","year":"2014","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.psychres.2018.11.041_bib0038","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.psychres.2018.11.041_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186384","article-title":"The association between serum brain-derived neurotrophic factor and a cluster of cardiovascular risk factors in adolescents: the CHAMPS-study DK","volume":"12","author":"Pedersen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2018.11.041_bib0040","article-title":"BDNF as a marker of response to cognitive remediation in patients with schizophrenia: a randomized and controlled trial","author":"Penades","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.11.041_bib0041","article-title":"Predicting relapse in schizophrenia: is BDNF a plausible biological marker?","author":"Pillai","year":"2017","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0042","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pnpbp.2004.05.008","article-title":"Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment","volume":"28","author":"Pirildar","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2018.11.041_bib0043","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neulet.2008.05.022","article-title":"Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia","volume":"439","author":"Reis","year":"2008","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.psychres.2018.11.041_bib0044","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.pnpbp.2008.04.007","article-title":"Investigation of serum BDNF levels in drug-naive patients with schizophrenia","volume":"32","author":"Rizos","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0045","first-page":"297","article-title":"Association of serum BDNF and val66met polymorphism of the brain-derived neurotrophic factor in a sample of first psychotic episode patients","volume":"20","author":"Rizos","year":"2009","journal-title":"Psychiatriki"},{"issue":"10","key":"10.1016\/j.psychres.2018.11.041_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17101766","article-title":"The efficacy of non-pharmacological interventions on brain-derived neurotrophic factor in schizophrenia: a systematic review and meta-analysis","volume":"17","author":"Sanada","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.psychres.2018.11.041_bib0047","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications","volume":"64","author":"Sen","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.11.041_bib0048","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajp.2013.11.017","article-title":"Association between antipsychotic-induced metabolic side-effects and clinical improvement: a review on the evidence for \"metabolic threshold\"","volume":"8","author":"Sharma","year":"2014","journal-title":"Asian J. Psychiatr."},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0049","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euroneuro.2004.12.005","article-title":"The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia","volume":"15","author":"Shoval","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.psychres.2018.11.041_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/pcn.12476","article-title":"Biological hypotheses and biomarkers of bipolar disorder","volume":"71","author":"Sigitova","year":"2017","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.psychres.2018.11.041_bib0051","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JCP.0000000000000378","article-title":"Lower brain-derived neurotropic factor levels in untreated adolescents with first-episode psychosis","volume":"35","author":"Simsek","year":"2015","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0052","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/08039488.2017.1415373","article-title":"Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters","volume":"72","author":"Skibinska","year":"2018","journal-title":"Nord. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0053","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S0033291714001925","article-title":"Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia","volume":"45","author":"Skilleter","year":"2015","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0054","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2014.07.033","article-title":"Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naive, first episode schizophrenia","volume":"159","author":"Song","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2018.11.041_bib0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.psychres.2016.05.019","article-title":"BDNF serum levels in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)","volume":"242","author":"Strzelecki","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2018.11.041_bib0056","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.psychres.2016.07.040","article-title":"Serum brain-derived neurotrophic factor levels associate with cognitive improvement in patients with schizophrenia treated with electroacupuncture","volume":"244","author":"Sun","year":"2016","journal-title":"Psychiatry Res."},{"issue":"1-2","key":"10.1016\/j.psychres.2018.11.041_bib0057","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.02.054","article-title":"Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics","volume":"382","author":"Tan","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"2-3","key":"10.1016\/j.psychres.2018.11.041_bib0058","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.schres.2004.08.004","article-title":"Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements","volume":"74","author":"Tan","year":"2005","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0059","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5498\/wjp.v5.i1.154","article-title":"Brain-derived neurotrophic factor levels in first episode of psychosis: a systematic review","volume":"5","author":"Toll","year":"2015","journal-title":"World J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2018.11.041_bib0060","first-page":"2115","article-title":"Waist-to-height ratio (WHtR) and triglyceride to HDL-C ratio (TG\/HDL-c) as predictors of cardiometabolic risk","volume":"31","author":"Weiler Miralles","year":"2015","journal-title":"Nutr. Hosp."},{"issue":"2","key":"10.1016\/j.psychres.2018.11.041_bib0061","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0014-4886(90)90068-4","article-title":"Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization","volume":"109","author":"Wetmore","year":"1990","journal-title":"Exp. Neurol."},{"issue":"9904","key":"10.1016\/j.psychres.2018.11.041_bib0062","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0063","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/08039488.2015.1087592","article-title":"Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia","volume":"70","author":"Wysokinski","year":"2016","journal-title":"Nord. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2018.11.041_bib0064","first-page":"1508","article-title":"Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Prog. Neuropsychopharmacol","volume":"33","author":"Xiu","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2018.11.041_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2013.09.059","article-title":"Plasma levels of mature brain-derived neurotrophic factor (BDNF) and matrix metalloproteinase-9 (MMP-9) in treatment-resistant schizophrenia treated with clozapine","volume":"556","author":"Yamamori","year":"2013","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0066","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2011.07.020","article-title":"Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia","volume":"502","author":"Yang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.psychres.2018.11.041_bib0067","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyy036","article-title":"Levels of serum brain-derived neurotropic factor in individuals at ultra-high risk for psychosis - findings from the Longitudinal Youth at Risk Study (LYRIKS)","author":"Yee","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0068","doi-asserted-by":"crossref","DOI":"10.1186\/s12991-015-0084-9","article-title":"Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia","volume":"15","author":"Yoshimura","year":"2016","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2018.11.041_bib0069","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.psyneuen.2014.09.029","article-title":"The interplay between BDNF and oxidative stress in chronic schizophrenia","volume":"51","author":"Zhang","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2018.11.041_bib0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.psyneuen.2014.06.004","article-title":"Gender difference in association of cognition with BDNF in chronic schizophrenia","volume":"48","author":"Zhang","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2018.11.041_bib0071","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbi.2015.09.014","article-title":"Interaction of BDNF with cytokines in chronic schizophrenia","volume":"51","author":"Zhang","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.psychres.2018.11.041_bib0072","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00213-010-1956-y","article-title":"Nicotine dependence and serum BDNF levels in male patients with schizophrenia","volume":"212","author":"Zhang","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"10.1016\/j.psychres.2018.11.041_bib0073","doi-asserted-by":"crossref","first-page":"e72652","DOI":"10.1371\/journal.pone.0072652","article-title":"Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.psychres.2018.11.041_bib0074","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00213-018-4835-6","article-title":"Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study","volume":"235","author":"Zhang","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.psychres.2018.11.041_bib0075","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pscychresns.2015.08.009","article-title":"Serum brain-derived neurotrophic factor and cortical thickness are differently related in patients with schizophrenia and controls","volume":"234","author":"Zugman","year":"2015","journal-title":"Psychiatry Res."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118307911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118307911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:28:58Z","timestamp":1759037338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178118307911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":75,"alternative-id":["S0165178118307911"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2018.11.041","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated brain-derived neurotrophic factor (BDNF) serum levels in an acute episode of schizophrenia in polish women: Correlation with clinical and metabolic parameters.","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2018.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}